MEDS logo

DATAMEDS AI INC

MEDSNASDAQ
πŸ† #4420 by market capUS Equity
$1.39β–Ό $0.18 (βˆ’13.12%)
πŸŒ… Pre-market$1.44β–² 3.60%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 13.1%
7dβ–Ό 59.7%
14dβ–Ό 55.9%
30dβ–Ό 53.5%
1yβ–Ό 96.1%
🏦Market Cap
$4M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+28.7%
High Growth
πŸ“ŠGross Margin
-69.2%
Thin
πŸ’΅FCF Margin
-93.4%
Thin
βš–οΈP/S Ratio
0.3x
Cheap
Otter Score
51
Weak

Trading Snapshot

Day Range
$1.38 – $1.41
52-Week Range
$1.32 – $97.50
Volume
$2.54B
Avg Volume
$1.84B
Shares Outstanding
2.6M
Next Earnings
Oct 24, 2026

Fundamentals Snapshot

Annual Revenue
$23M
Last Q Revenue
$2M
P/E Ratio
-0.0
P/S Ratio
0.3x
EPS (TTM)
$-53.94
Dividend Yield
0.00%

Why Investors Own MEDS

  • βœ“High-growth profile β€” revenue up +48.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 25% gross margin and 9% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$23Mβ–² +49.3% YoY
Gross Margin (TTM)
25.2%β–² +4.4% YoY
Operating Income (TTM)
$5Mβ–² +49.3% YoY
Free Cash Flow (TTM)
$2Mβ–² +49.3% YoY

About DATAMEDS AI INC

DataMEDS AI is a Health IT company focused on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units. The company incorporates its artificial intelligence platform EinsteinRxβ„’ and blockchain-enabled smart contacts platform PharmacyChainβ„’ to optimize the prescription medicines reimbursement and dispensing journey.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
51/100

Analyst Price Target

β“˜
Average Target
$1.37
β–Ό βˆ’1.5% Downside
High Target$1.58
Low Target$1.11
Based on 29 analysts

Latest News & Updates